Home » Newsletters » BioWorld Science

BioWorld Science

May 14, 2013

View Archived Issues

Preclinical and clinical safety data for EBI-005 presented

GTx-758 effectively suppresses testosterone in males with prostate cancer

BL-8030 shows potency, selectivity and a promising pharmacokinetic profile

Merck KGaA presents novel TGFR-1 inhibitor with in vivo antitumor activity

Lexicon advances LX-4211 to expansion portion of phase II trial

PRELUDE study of enzastaurin fails to meet primary endpoint

ALS Emergency Treatment Fund and Denovo Biomarkers establish partnership

Arno Therapeutics and Clarient to develop companion diagnostic

Serum CYPA as a novel biomarker of atherosclerotic diseases

Researchers develop novel vaccine with the potential to block tumor foci formation

Dainippon Sumitomo Pharma reflects on accomplishments of fiscal 2012

Chinese group presents new DHODH inhibitors

Novel compounds inhibiting deubiquitinating activity patented by Vivolux

Sirtris Pharmaceuticals discloses new hSIRT1 activators

Bayer Intellectual Property divulges novel HIF-1 inhibitors

Pan-genomic anti-HCV activity disclosed for tetrahydroquinolines

Novavax commences animal testing with H7N9 VLP influenza vaccine

FDA accepts Biogen Idec's Eloctate BLA for filing

Starpharma's SPL-7013 shows potential to treat viral conjunctivitis

Mirna Therapeutics advances miRNA MRX-34 into phase I

MorphoSys begins new phase II trial of MOR-208 in NHL

Actavis and Warner Chilcott discuss potential business combination

Relypsa completes enrollment in pivotal phase III trial of patiromer

FDA grants priority review to simeprevir NDA

FDA approves first nimodipine oral solution

Sorrento Therapeutics and Igdrasol acquire E.U. rights to Cynviloq

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...